1. Home
  2. TVTX vs UNIT Comparison

TVTX vs UNIT Comparison

Compare TVTX & UNIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • UNIT
  • Stock Information
  • Founded
  • TVTX 2008
  • UNIT 2015
  • Country
  • TVTX United States
  • UNIT United States
  • Employees
  • TVTX N/A
  • UNIT N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • UNIT Real Estate Investment Trusts
  • Sector
  • TVTX Health Care
  • UNIT Real Estate
  • Exchange
  • TVTX Nasdaq
  • UNIT Nasdaq
  • Market Cap
  • TVTX 1.3B
  • UNIT 1.3B
  • IPO Year
  • TVTX N/A
  • UNIT N/A
  • Fundamental
  • Price
  • TVTX $17.72
  • UNIT $5.58
  • Analyst Decision
  • TVTX Buy
  • UNIT Buy
  • Analyst Count
  • TVTX 13
  • UNIT 3
  • Target Price
  • TVTX $23.46
  • UNIT $7.17
  • AVG Volume (30 Days)
  • TVTX 1.4M
  • UNIT 2.3M
  • Earning Date
  • TVTX 10-31-2024
  • UNIT 10-31-2024
  • Dividend Yield
  • TVTX N/A
  • UNIT 10.73%
  • EPS Growth
  • TVTX N/A
  • UNIT N/A
  • EPS
  • TVTX N/A
  • UNIT 0.42
  • Revenue
  • TVTX $203,447,000.00
  • UNIT $1,159,268,000.00
  • Revenue This Year
  • TVTX $62.45
  • UNIT N/A
  • Revenue Next Year
  • TVTX $59.30
  • UNIT $2.93
  • P/E Ratio
  • TVTX N/A
  • UNIT $13.16
  • Revenue Growth
  • TVTX 57.08
  • UNIT 0.99
  • 52 Week Low
  • TVTX $5.12
  • UNIT $2.57
  • 52 Week High
  • TVTX $20.33
  • UNIT $6.71
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 51.53
  • UNIT 49.83
  • Support Level
  • TVTX $16.89
  • UNIT $5.43
  • Resistance Level
  • TVTX $19.51
  • UNIT $6.08
  • Average True Range (ATR)
  • TVTX 1.23
  • UNIT 0.26
  • MACD
  • TVTX -0.16
  • UNIT -0.02
  • Stochastic Oscillator
  • TVTX 26.69
  • UNIT 53.70

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About UNIT Uniti Group Inc.

Uniti is a REIT with about 140,000 route miles of fiber in the us, primarily in the Southeast. It has agreed to merge with Windstream, which will result in Uniti giving up its REIT status and adding a consumer telecom business line. Uniti's business currently consists exclusively of fiber leasing to enterprises. Windstream currently leases the Uniti network and makes up the bulk of Uniti's revenue and profits. The combined firm will own 217,000 route miles of fiber and pass 4.3 million households and 150,000 commercial buildings, mostly in less populated markets in the Southeast. The firm will continue to offer fiber access to enterprises, as Uniti currently does, but residential telecom services will become its largest revenue stream.

Share on Social Networks: